Durable responses to Erlotinib despite KRAS mutations in two patients with metastatic lung adenocarcinoma. (Q43054632)
Jump to navigation
Jump to search
scientific article published in June 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Durable responses to Erlotinib despite KRAS mutations in two patients with metastatic lung adenocarcinoma. |
scientific article published in June 2010 |
Statements
Durable responses to Erlotinib despite KRAS mutations in two patients with metastatic lung adenocarcinoma (English)
C Ferté
B Besse
E Dansin
F Parent
M-P Buisine
M-C Copin